[COVID-19 vaccine and anticoagulation patients at high cardiovascular risk. SEMERGEN recommendations].

Pallarés-Carratalá, VPolo García, JMartín Rioboo, ERuíz García, ASerrano-Cumplido, ABarrios, Ven nombre del Grupo de trabajo de Hipertensión y Enfermedad Cardiovascular de SEMERGEN2023-02-092023-02-092021-01-02http://hdl.handle.net/10668/17018esAnticoagulantsBNT162 VaccineCOVID-19COVID-19 VaccinesCardiovascular DiseasesHeart Disease Risk FactorsHumansRNA, MessengerRisk FactorsSARS-CoV-2[COVID-19 vaccine and anticoagulation patients at high cardiovascular risk. SEMERGEN recommendations].Vacuna COVID-19 y pacientes anticoagulados por alto riesgo cardiovascular. Recomendaciones SEMERGEN.research article33478841open access10.1016/j.semerg.2020.12.0051578-8865PMC7832064https://doi.org/10.1016/j.semerg.2020.12.005https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832064/pdf